3.1500
-0.0200
(-0.63%)
At close: January 10 at 4:00:00 PM EST
3.0400
-0.11
(-3.49%)
After hours: January 10 at 6:18:02 PM EST
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Expense
17,826.0000
9,584.0000
8,869.0000
7,208.0000
1,671.0000
Operating Income
-17,826.0000
-9,584.0000
-8,869.0000
-7,208.0000
-1,671.0000
Net Non Operating Interest Income Expense
-1,573.0000
-1,480.0000
147.0000
-10.0000
-1,055.0000
Other Income Expense
1,734.0000
1,728.0000
-61.0000
-22.0000
-1,107.0000
Pretax Income
-17,665.0000
-9,336.0000
-8,783.0000
-7,240.0000
-3,833.0000
Tax Provision
--
8.0000
9.0000
6.0000
220.0000
Net Income Common Stockholders
-17,673.0000
-9,344.0000
-8,792.0000
-7,246.0000
-4,053.0000
Diluted NI Available to Com Stockholders
-17,673.0000
-9,344.0000
-8,792.0000
-7,246.0000
-4,053.0000
Basic EPS
-6.14
-7.14
-8.13
-7.25
-12.50
Diluted EPS
-6.14
-7.14
-8.13
-7.25
-12.50
Basic Average Shares
2,820.7720
1,308.9200
1,081.7550
999.5620
324.3940
Diluted Average Shares
2,820.7720
1,308.9200
1,081.7550
999.5620
324.3940
Total Operating Income as Reported
-17,826.0000
-9,584.0000
-8,869.0000
-7,208.0000
-1,671.0000
Rent Expense Supplemental
--
191.0000
249.0000
210.0000
37.0000
Total Expenses
17,826.0000
9,584.0000
8,869.0000
7,208.0000
1,671.0000
Net Income from Continuing & Discontinued Operation
-17,673.0000
-9,344.0000
-8,792.0000
-7,246.0000
-4,053.0000
Normalized Income
-19,407.0000
-10,674.5600
-8,745.0300
-7,229.0600
-3,200.6100
Interest Income
314.0000
406.0000
160.0000
--
--
Interest Expense
--
--
--
--
987.0000
Net Interest Income
-1,573.0000
-1,480.0000
147.0000
-10.0000
-1,055.0000
EBIT
-17,826.0000
-9,584.0000
-8,869.0000
-7,208.0000
-2,846.0000
EBITDA
-17,809.0000
-9,569.0000
-8,854.0000
-7,201.0000
-2,846.0000
Reconciled Depreciation
17.0000
15.0000
15.0000
7.0000
--
Net Income from Continuing Operation Net Minority Interest
-17,673.0000
-9,344.0000
-8,792.0000
-7,246.0000
-4,053.0000
Total Unusual Items Excluding Goodwill
1,734.0000
1,728.0000
-61.0000
-22.0000
-1,107.0000
Total Unusual Items
1,734.0000
1,728.0000
-61.0000
-22.0000
-1,107.0000
Normalized EBITDA
-19,543.0000
-11,297.0000
-8,793.0000
-7,179.0000
-1,739.0000
Tax Rate for Calcs
--
0.0002
0.0002
0.0002
0.0002
Tax Effect of Unusual Items
--
397.4400
-14.0300
-5.0600
-254.6100
12/31/2020 - 9/1/2020
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
UPC Universe Pharmaceuticals INC
0.6299
+1.93%
PTPI Petros Pharmaceuticals, Inc.
0.3761
+3.32%
AKAN Akanda Corp.
1.5600
-3.11%
CPHI China Pharma Holdings, Inc.
0.2199
+4.17%
SXTC China SXT Pharmaceuticals, Inc.
0.4693
-1.82%
BFRI Biofrontera Inc.
1.1200
-5.08%
YCBD cbdMD, Inc.
0.5630
+13.28%
CLSH CLS Holdings USA, Inc.
0.0316
+5.33%
QNTM Quantum BioPharma Ltd.
3.5400
-5.85%
CPIX Cumberland Pharmaceuticals Inc.
2.3300
+4.48%